July 26, 2021
ALPHARETTA, Ga. – In this new video interview with Visioneering Technologies, Inc. (VTI), CEO Dr. Stephen Snowdy shares the news, “We’re getting ready to kick off a randomized controlled clinical trial” following last year’s release of “five-year data for NaturalVue multifocal in the management of myopia in children.”
In this interview with John Sailer, Editor-in-Chief of Review of Myopia Management, Dr. Snowdy describes how VTI got its start and went from a company looking for a different kind of multifocal contact lens for presbyopia to an additional direction with its NaturalVue multifocal center-distance lens that was CE marked for myopia progression control, an indication that was then picked up in Australia, Singapore, and Canada. Dr. Snowdy also shares his definition of myopia management and everything that it encompasses.
Check out this new RMM video interview with VTI here: